A novel immunoadsorption device for removing β2-microglobulin from whole blood
- 1 April 2001
- journal article
- Published by Elsevier in Kidney International
- Vol. 59 (4) , 1544-1550
- https://doi.org/10.1046/j.1523-1755.2001.0590041544.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- RTD analysis of a novel Taylor‐Couette flow device for blood detoxificationAIChE Journal, 1999
- β2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblastsKidney International, 1998
- Interaction between β2-microglobulin and advanced glycation end products in the development of dialysis related-amyloidosisKidney International, 1997
- How to measure and predict the molar absorption coefficient of a proteinProtein Science, 1995
- beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.Journal of Clinical Investigation, 1993
- An Experimental Study on Selective Elimination of β2-Microglobulin Using Immunoadsorption Method in Patients with Chronic Renal FailureBiomaterials, Artificial Cells and Immobilization Biotechnology, 1991
- Extracorporeal enzymatic heparin removal: Use in a sheep dialysis modelKidney International, 1987
- A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulinBiochemical and Biophysical Research Communications, 1985
- An Enzymatic System for Removing Heparin in Extracorporeal TherapyScience, 1982
- Characterization of a monoclonal anti‐β2‐microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigensEuropean Journal of Immunology, 1979